TNF Pharmaceuticals (TNFA) announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was presented last week in a podium session at the ...

In vitro tests indicate that cannabidiol can stimulate the biomineralization of teeth even under inflammatory conditions, ...

TNF Pharmaceuticals (TNFA) announced the initiation of a fully funded Phase 2b clinical trial evaluating oral TNF-alpha inhibitor drug ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Until about ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

agents Anti-TNF agents bind to and block the protein called tumor necrosis factor-alpha (TNF-alpha). In people with UC, this protein causes inflammation in the: intestines organs tissues Blocking ...

Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...

In the experiment, cells from the dental pulp of mice were exposed to a cytokine called tumor necrosis factor alpha (TNF-α), ...